Cargando…
Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells
BACKGROUND: Mesenchymal stem cells (MSCs) are a mixture of progenitors that are heterogeneous in their regenerative potential. Development of MSC therapies with consistent efficacy is hindered by the absence of an immunophenotype of MSC heterogeneity. This study evaluates decoy TRAIL receptor CD264...
Autores principales: | Madsen, Sean D., Russell, Katie C., Tucker, H. Alan, Glowacki, Julie, Bunnell, Bruce A., O’Connor, Kim C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622446/ https://www.ncbi.nlm.nih.gov/pubmed/28962588 http://dx.doi.org/10.1186/s13287-017-0649-4 |
Ejemplares similares
-
Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells
por: Sanlioglu, Ahter D, et al.
Publicado: (2005) -
Cellular decoys distract coronavirus
por: Bradley, David
Publicado: (2020) -
TRAIL Death Receptor-4, Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8(+ )T Cells Correlate with the Disease Severity in Patients with Rheumatoid Arthritis
por: Bisgin, Atil, et al.
Publicado: (2010) -
MicroRNA profiling reveals age-dependent differential expression of nuclear factor κB and mitogen-activated protein kinase in adipose and bone marrow-derived human mesenchymal stem cells
por: Pandey, Amitabh C, et al.
Publicado: (2011) -
Reduction of Decoy Receptor 3 Enhances TRAIL-Mediated Apoptosis in Pancreatic Cancer
por: Wang, Wei, et al.
Publicado: (2013)